Clinical trials were conducted on iloperidone in search of a safer and more efficacious treatment for schizophrenia, however, the results from the previous trials are non-conclusive. This meta-analysis was conducted to evaluate the efficacy and safety of iloperidone in patients with schizophrenia.
The review...
S. Kimi, Shampa Maji, B. Mishra et al.· Annals of Clinical Psychiatr...· 0 citations
Combining prospective sample size inflation with MI enhances internal validity and power in RCTs facing attrition, and has important implications for clinical trial guidelines, especially in sample size estimation and missing data handling.
A. Mishra, Anand Srinivasan, R. Maiti et al.· British Journal of Clinical...· 0 citations
This review summarizes the current evidence on non-antibiotic therapeutics including bacteriophages, antimicrobial peptides, anti-virulence agents, monoclonal antibodies, microbiome-based therapies, CRISPR-Cas systems, nanoparticles, photodynamic therapy, repurposed non-antibiotic drugs and combination strategies.
B. Ganesan, A. Mishra, Debasish Hota et al.· Expert Review of Clinical Ph...· 0 citations
BACKGROUND: Schizophrenia has traditionally been conceptualized through dopaminergic and glutamatergic frameworks. In recent years, attention has increasingly focused on the role of immune dysregulation in its pathophysiology, although conclusive evidence remains limited. In this context, the present study aimed to inv...
Aashima Handa, A. Mishra, S. Sarangi et al.· Indian Journal of Pharmacolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
